**Core Concept**
The patient's symptoms, particularly the pruritic erythematous rash and joint pain following an upper respiratory tract infection, suggest an allergic reaction to a medication. Cefaclor is a second-generation cephalosporin antibiotic known for its potential to cause an immune-mediated reaction, specifically a condition known as **drug rash with eosinophilia and systemic symptoms (DRESS)**.

**Why the Correct Answer is Right**
The patient's history of taking cefaclor for 7 days, followed by the development of a rash, joint pain, and lymph node enlargement, is highly suggestive of a drug reaction. Cefaclor can cause an immune-mediated reaction, leading to the release of cytokines and the activation of eosinophils, resulting in the characteristic skin rash and systemic symptoms.

**Why Each Wrong Option is Incorrect**
**Option A:** Stevens-Johnson Syndrome (SJS) is a severe cutaneous adverse reaction that can be caused by medications, but it typically presents with mucosal involvement, which is not mentioned in the patient's symptoms.
**Option B:** Kawasaki disease is a condition that affects the blood vessels and can present with fever, rash, and joint pain, but it is not typically associated with medication use.
**Option C:** Henoch-Schönlein purpura (HSP) is a vasculitic condition that can present with rash, joint pain, and abdominal pain, but it is not typically associated with medication use.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with a rash and joint pain, it is essential to consider the possibility of a drug reaction, particularly if the patient has been taking medications recently. The timing and pattern of the symptoms can provide clues to the diagnosis.

**Correct Answer:** D. Drug rash with eosinophilia and systemic symptoms (DRESS)